Skip to main content
Deciphera
  • Our Company
    • Who We Are
    • Leadership
  • Focus Areas
    • Overview
    • Oncology
    • Immunology & Inflammation
    • Neurology
  • Pipeline
    • Ongoing Clinical Trials
    • Presentations & Publications
  • Patients & Care Partners
    • Expanded Access
  • Healthcare Professionals (Coming soon!)
  • Our Medicines
  • Join Us
    • Our Culture
    • Open Positions
  • News
November 09, 2025
Vimseltinib
ISPOR EU 2025

Health-related Quality of Life Measured by EQ-5D Utility Scores among Patients with TGCT: A Trial-based Analysis of EQ-5D Data from Patients in the MOTION Trial

Subscribe to ISPOR EU 2025

© 2026 Deciphera. All Rights Reserved.

  • Privacy Policy
  • Contact Us
  • Terms of Use
linkedin twitter
Back to top